SEQUENOM INC 4

Accession 0001209191-16-140407

CIK 0001076481operating

Filed

Sep 6, 8:00 PM ET

Accepted

Sep 7, 4:39 PM ET

Size

23.5 KB

Accession

0001209191-16-140407

Form 4

Period: 2016-09-07

Sr VP Reg Affairs & Quality

Transactions

Disposition from Tender
Common Stock
2016-09-07−37,238→ 0 total
Disposition to Issuer
Incentive Stock Option (right to buy)
2016-09-07−50,875→ 0 total
Exercise: $1.59Exp: 2026-01-25→ Common Stock (50,875 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2016-09-07−15,125→ 0 total
Exercise: $1.59Exp: 2026-01-25→ Common Stock (15,125 underlying)
Disposition to Issuer
Restricted Stock Unit
2016-09-07−11,000→ 0 total
→ Common Stock (11,000 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2016-09-07−23,292→ 0 total
Exercise: $2.27Exp: 2024-01-31→ Common Stock (23,292 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2016-09-07−19,708→ 0 total
Exercise: $2.27Exp: 2024-01-31→ Common Stock (19,708 underlying)
Disposition to Issuer
Restricted Stock Unit
2016-09-07−15,000→ 0 total
→ Common Stock (15,000 underlying)
Disposition to Issuer
Restricted Stock Unit
2016-09-07−50,000→ 0 total
→ Common Stock (50,000 underlying)
Disposition to Issuer
Restricted Stock Unit
2016-09-07−6,500→ 0 total
→ Common Stock (6,500 underlying)

Footnotes (4)

[F1]Disposed of pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated July 26, 2016, among the Issuer, Laboratory Corporation of America Holdings, a Delaware corporation ("Parent"), and Savoy Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser") in exchange for a cash consideration of $2.40 per share, without interest, subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the "Merger").
[F2]This option was cancelled in the Merger in exchange for a cash payment equal to $2.40 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger.
[F3]Each restricted stock unit (the "RSUs") represents a contingent right to receive one share of the Issuer's Common Stock.
[F4]These RSUs were cancelled in the Merger and, in lieu of any issuance of shares in settlement of such vested RSUs, converted into the right to receive a cash payment equal to $2.40 per share (without interest). In connection with the Merger, vesting of the RSUs was accelerated and the RSUs became fully vested effective immediately prior to the effective time of the Merger.

Documents

1 file

SEQUENOM INC

CIK 0001076481

Entity typeoperating

IncorporatedDE